Rivastigmine Base*
-
API Product :
Rivastigmine Base*
-
CEP :
¤
-
WCC :
?
-
Therapeutic Use :
Psychoanaleptics Excluding Anti-Obesity Preparations; Other CNS Drugs
-
Originator :
Novartis
-
CAS No. :
123441-03-2
-
Trade Name. :
EXELON
-
Molecular Weight :
250.337 g/mol
-
Molecular Formula :
C14H22N2O2
Application
Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions.
General Description
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects,[1] which typically include nausea and vomiting.[2] The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.